Year archive

Antengene Corporation Limited — 2025 filings

All 37 regulatory filings released by Antengene Corporation Limited (6996) in 2025, sourced directly from the official regulator.

37 Filings

2025 Period

2025 filings (37)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT XPOVIO APPROVED IN MALAYSIA FOR A NEW INDICATION IN DIFFUSE LARGE B-CELL LYMPHOMA Regulatory Filings	2025-12-16	English
Nomination and Corporate Governance Committee - Terms of Reference Governance Information	2025-12-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-04	English
VOLUNTARY ANNOUNCEMENT XPOVIO APPROVED IN HONG KONG FOR TWO ADDITIONAL INDICATIONS IN MULTIPLE MYELOMA AND DIFFUSE LARGE B-CELL LYMPHOMA Regulatory Filings	2025-12-03	English
VOLUNTARY ANNOUNCEMENT IND APPROVAL IN CHINA FOR PHASE IB/II STUDY OF ATG-022 IN COMBINATION WITH KEYTRUDA (PEMBROLIZUMAB) CHEMOTHERAPY Regulatory Filings	2025-12-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-08	English
2025 INTERIM REPORT Interim / Quarterly Report H1 2025	2025-09-29	English
Next Day Disclosure Return Transaction in Own Shares	2025-09-16	English
Next Day Disclosure Return Transaction in Own Shares	2025-09-11	English
Next Day Disclosure Return Transaction in Own Shares	2025-09-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-04	English
VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE Transaction in Own Shares	2025-09-01	English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H1 2025	2025-08-22	English
VOLUNTARY ANNOUNCEMENT ATG-022 GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR THE TREATMENT OF GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA Regulatory Filings	2025-08-19	English
NOTICE OF DATE OF BOARD MEETING Report Publication Announcement	2025-08-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Regulatory Filings	2025-08-04	English
VOLUNTARY ANNOUNCEMENT XPOVIO APPROVED IN CHINA FOR THE SECOND-LINE TREATMENT OF MULTIPLE MYELOMA Regulatory Filings	2025-07-28	English
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG Regulatory Filings	2025-07-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-03	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 13, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Share Issue/Capital Change	2025-06-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-08	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-27	English
NOTICE OF THE ANNUAL GENERAL MEETING AGM Information	2025-04-27	English
(1) PROPOSALS FOR GENERAL MANDATES TO ISSUE AND RESELL SHARES AND TO REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; AND (3) NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-27	English
2024 ANNUAL REPORT Annual Report FY 2024	2025-04-27	English
VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE Transaction in Own Shares	2025-04-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Capital/Financing Update	2025-04-07	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024 Earnings Release FY 2024	2025-03-21	English
NOTICE OF DATE OF BOARD MEETING Regulatory Filings	2025-03-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Share Issue/Capital Change	2025-03-05	English
VOLUNTARY ANNOUNCEMENT APPROVAL OF NDA BY THE INDONESIA NATIONAL AGENCY OF DRUG AND FOOD CONTROL FOR XPOVIO Regulatory Filings	2025-03-05	English
VOLUNTARY ANNOUNCEMENT BUSINESS PROGRESS AND UPDATE Regulatory Filings	2025-02-19	English
VOLUNTARY ANNOUNCEMENT APPROVAL OF XPOVIO FOR PUBLIC HEALTH INSURANCE COVERAGE IN TAIWAN Regulatory Filings	2025-02-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Share Issue/Capital Change	2025-01-06	English